AU2347692A - Recombinant viral vaccine - Google Patents

Recombinant viral vaccine

Info

Publication number
AU2347692A
AU2347692A AU23476/92A AU2347692A AU2347692A AU 2347692 A AU2347692 A AU 2347692A AU 23476/92 A AU23476/92 A AU 23476/92A AU 2347692 A AU2347692 A AU 2347692A AU 2347692 A AU2347692 A AU 2347692A
Authority
AU
Australia
Prior art keywords
recombinant viral
viral vaccine
vaccine
recombinant
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23476/92A
Inventor
Christopher K Ngichabe
Fredric W. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of AU2347692A publication Critical patent/AU2347692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU23476/92A 1991-07-09 1992-07-08 Recombinant viral vaccine Abandoned AU2347692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72660991A 1991-07-09 1991-07-09
US726609 1991-07-09

Publications (1)

Publication Number Publication Date
AU2347692A true AU2347692A (en) 1993-02-11

Family

ID=24919294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23476/92A Abandoned AU2347692A (en) 1991-07-09 1992-07-08 Recombinant viral vaccine

Country Status (2)

Country Link
AU (1) AU2347692A (en)
WO (1) WO1993001284A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132742C (en) * 1993-01-23 2000-04-18 Carmen Vela Olmo Synthetic peptides and vaccines against parvovirus
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
US6106841A (en) * 1998-02-04 2000-08-22 Heska Corporation Delivery method for recombinant raccoon poxvirus
CN1258596C (en) 2001-03-08 2006-06-07 阿克佐诺贝尔公司 Leporipox-based vector vaccines
WO2017106079A1 (en) 2015-12-14 2017-06-22 Boehringer Ingelheim Vetmedica, Inc. Hybrid core feline vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine

Also Published As

Publication number Publication date
WO1993001284A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
AU4325089A (en) Viral vaccines
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU1628895A (en) Recombinant virus
EP0717636A4 (en) Malaria recombinant poxvirus vaccine
EP0708658A4 (en) Recombinant cytomegalovirus vaccine
GB2245272B (en) Recombinant virus selection system
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
CZ197595A3 (en) Vaccine preparations
GB9115909D0 (en) Recombinant dna
GB9105992D0 (en) Vaccine
AU3601689A (en) Recombinant coccidiosis vaccines
HUP9601462A2 (en) Adjuvants for viral vaccines
LTIP335A (en) Vaccine for human immunodeficiency virus
AU4450093A (en) Hepatitis A virus vaccine
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
AU7617791A (en) Recombinant immunocastration vaccine
IL101639A0 (en) Recombinant influenza vaccines
AU5679394A (en) Hepatitis b virus vaccines
AU6715094A (en) Recombinant vaccine
AU2347692A (en) Recombinant viral vaccine
AU1668097A (en) Malaria recombinant poxvirus vaccine
AU635036B2 (en) Recombinant avipoxvirus
AU2775692A (en) Recombinant influenza virus vaccine compositions
HU9203976D0 (en) Vaccine based on modified herpes virus
EP0537232A4 (en) Recombinant pigeon pox virus vaccine